3MSJ
Structure of bace (beta secretase) in complex with inhibitor
3MSJ の概要
| エントリーDOI | 10.2210/pdb3msj/pdb |
| 分子名称 | BETA-SECRETASE 1, 3-(2-amino-5-chloro-1H-benzimidazol-1-yl)propan-1-ol, GLYCEROL, ... (4 entities in total) |
| 機能のキーワード | protease, alzheimer's disease, aspartic protease, aspartyl protease, base, beta-secretase, glycoprotein, hydrolase, memapsin 2, amyloid precursor protein secretases, aspartic endopeptidases, fragment-based drug design, fluorescence polarisation, transmembrane, zymogen, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
| 由来する生物種 | HOMO SAPIENS (HUMAN) |
| 細胞内の位置 | Membrane; Single-pass type I membrane protein: P56817 |
| タンパク質・核酸の鎖数 | 3 |
| 化学式量合計 | 139625.74 |
| 構造登録者 | Madden, J.,Kramer, J.,Smith, M.A.,Barker, J.,Godemann, R. (登録日: 2010-04-29, 公開日: 2010-07-14, 最終更新日: 2024-10-16) |
| 主引用文献 | Madden, J.,Dod, J.R.,Godemann, R.,Kraemer, J.,Smith, M.,Biniszkiewicz, M.,Hallett, D.J.,Barker, J.,Dyekjaer, J.D.,Hesterkamp, T. Fragment-based discovery and optimization of BACE1 inhibitors. Bioorg.Med.Chem.Lett., 20:5329-5333, 2010 Cited by PubMed Abstract: A novel series of 2-aminobenzimidazole inhibitors of BACE1 has been discovered using fragment-based drug discovery (FBDD) techniques. The rapid optimization of these inhibitors using structure-guided medicinal chemistry is discussed. PubMed: 20656487DOI: 10.1016/j.bmcl.2010.06.089 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.8 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






